This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

I read with concern the article by Gill et al,¹ published in the July 22, 2002, issue of the ARCHIVES, which describes an episode of massive bleeding in a woman whose regular medications included pentosan polysulfate sodium (Elmiron; Alza Pharmaceuticals, Mountain View, Calif). This report is seriously misleading and raises an unnecessary and probably groundless alarm concerning pentosan polysulfate.

Most troubling is the authors' omission of critical clinical information from the abstract of the article. The abstract does not mention the laceration of the carotid artery, the patient's chronic malnourished disease state, or the unknown status of her clotting factors before surgery. In fact, after reading the abstract, one is left with the very misleading impression that the patient simply walked in off the street with a spontaneous and massive hemorrhage, which was definitely not the case. Unfortunately, the abstract of this article will enjoy far wider readership than the . . . [Full Text of this Article]

RELATED ARTICLE

Misleading Report of Massive Bleeding in a Patient Taking Pentosan Polysulfate
Sharlene Gill, Sheldon C. Naiman, Abeed Jamal, and Linda M. Vickars
Arch Intern Med. 2003;163(1):119.
EXTRACT | FULL TEXT